New procedure codes in Belgian Nomenclature came into force in March 2020

08

Apr 2020

In March 2020, the Nomenclature was updated. The update brought changes regarding the creation of new codes, deletion of codes, modification of existing codes, and reimbursement conditions.

The health benefit Nomenclature of the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) includes the services (with specific hospital and ambulatory codes) that are reimbursed by the compulsory health care insurance, wholly or partially. The Nomenclature and its changes are published in the Belgian Official Gazette.

The changes of the following articles of the Nomenclature come into force on March 1, 2020:

Key changes in the General (1) article:

  • Modifications of §8 regarding the period of essential medical documentation keeping – it should be at least five years (reports, documents, plots, graphics mentioned in the nomenclature, X-ray and laboratory analysis results)

Key changes in the Otorhinolaryngology (14) article:

  • Modifications of existing codes were made (video head impulse test, VHIT) was added to the labyrinth examination 257611-257622)
  • New reimbursement conditions were added

Key changes in the Radiology (17) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Radiotherapy and radium therapy – nuclear medicine (18) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Clinical biology (24) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Anatomical pathology (32) article:

  • The following code was added:

589853-589864 “Fees for cytopathological screening examination for neoplastic cells in cervico-vaginal sample, using the liquid phase cytology, regardless of the number of samples”

  • Modifications of existing codes were made
  • One code was removed - 588350 – 588361
  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

Key changes in the Genetic examinations (33) article:

  • Minor modifications of reimbursement conditions were made, according to Article 1 §8 changes

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more